Physicians' Prescribing Patterns for Patients with Diabetes Are Changing for the Better - 23/10/12
| Funding: None. |
|
| Conflict of Interest: Dr Rodbard conducts clinical research, serves on advisory panels, consults, and lectures with support from Amylin, BMS, Boehringer Ingelheim, Lilly, Merck, Novo Nordisk, Roche, and Sanofi. Dr Jellinger serves on advisory panels, consults, and lectures with support from Amylin, Boehringer Ingelheim, Lilly, Merck, and Novo Nordisk. |
|
| Authorship: Both authors had access to the data and a role in writing the manuscript. |
Vol 125 - N° 11
P. e11-e12 - novembre 2012 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
